Clinical Trials for PD-L1 Negative

Find clinical trials for pd-l1 negative. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

NCT ID: NCT04468061

This clinical trial is studying a new treatment approach for patients with metastatic triple-negative breast cancer (TNBC) that does not express a protein called PD-L1. The trial is testing two inv...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Chicago, Illinois, United States +10 more

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

NCT ID: NCT05382299

This clinical trial is studying a new treatment called sacituzumab govitecan-hziy (SG) for patients with locally advanced or metastatic triple-negative breast cancer (TNBC) that has not been treate...

Recruiting

Phase: PHASE3 Type: interventional Locations: Ann Arbor, Michigan, United States, Boston, Massachusetts, United States +563 more

Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

NCT ID: NCT06288360

This clinical trial is investigating a new treatment approach for women with locally advanced cervical cancer that shows low levels of a protein called PD-L1. The treatment combines chemotherapy wi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Wuhan, Hubei, China, Shenyang, Liaoning, China +10 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions